why choose us

First received: June 09, 2023

Clinical Trial: Buprenorphine for Cancer Pain

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer-Related Pain

Study Type: INTERVENTIONAL


Official Title: Effective Use of Buprenorphine for Long-Acting Pain Relief in Combination With Short-Acting Full Agonist Opioids for Cancer Related Pain

Brief Summary: This study will evaluate patients on both buprenorphine and full agonist opioids (FAO) to assess for withdrawal symptoms.Patients will be evaluated by clinicians and using validated tools to assess for pain and withdrawal.At the same time, patients will use a CPM Rx application on their phone to track medication use.

Read more